IUCLID datasets with further data on the dangerous characteristics of 75 chemicals from 370 tests were made available. This more than doubles the amount of data that was first made available when the collaborative endeavour began a year ago so that the scientific community might create alternative test methods.

An updated set of archival data from unpublished chemical tests is now accessible on the IUCLID website thanks to a pilot effort run by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and assisted by ECHA.

In total, data from 517 tests on 94 compounds' danger qualities is now available in the database. This comes after the project's initial data transfer a year ago. With the aim of reducing the reliance on animal testing, this data may be used, for instance, to construct predictive computer testing models, read-across tests, and other alternative test methods.


The EFPIA and ECHA collaborated on this project to disseminate data on compounds that were primarily investigated to create drug syntheses. The European pharmaceuticals industry is represented by EFPIA.

Bayer AG, Boehringer Ingelheim, F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson, Merck KGaA, and Novartis are among the pharmaceutical firms taking part in the effort. Any institution or person who needs to record, save, submit, and communicate data on chemical compounds using standardized templates should use IUCLID. It was created by the OECD and ECHA together.

Reference: https://echa.europa.eu/-/efpia-and-echa-publish-more-data-to-help-developing-alternative-methods-to-animal-tests

Reach out to our regulation experts on product regulatory compliances